Intervention
Pristiq
ClinicalTrials.gov intervention label
Clinical trials
4 shownA Study of LY03005 vs PristiqNCT03733574 · 2018-06-19
COMPLETEDRelative Bioavailability (RBA) Study of LY03005 vs Pristiq®NCT03357796 · 2017-11-27
COMPLETEDPilot BA Study of New LY03005 vs PristiqNCT02988024 · 2016-12-07
COMPLETEDSafety, Tolerability and Pharmacokinetics Study of LY03005NCT02055300 · 2014-02-01
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED4
Phase mix
PHASE14
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.